ABOUT US

Lanier Biotherapeutics advances medical treatments to improve quality of living

We discover and develop antibody treatments to restore and improve better health: seeing, breathing, and believing!

ABOUT US

Lanier Biotherapeutics advances medical treatments to improve quality of living

We discover and develop antibody treatments to restore and improve better health: seeing, breathing, and believing!

OUR PROGRAMS

Advancing lead programs in immune checkpoint inhibitor (ICI) pneumonitis and beyond

The Ideal Treatment for Checkpoint Inhibitor Pneumonitis (CIP)

Protection from pulmonary fibrosis with checkpoint inhibitor amplification

Type 2 Inflammation / Fibrosis

Moderate-to-severe conditions, like asthma, atopic dermatitis, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis and food allergies, with limited response to corticosteroid treatment

Retinal

Biobetter multifunctional anti-VEGF antibodies

The Ideal Treatment for Checkpoint Inhibitor Pneumonitis (CIP)

Protection from pulmonary fibrosis with tumor suppression

Type 2 Inflammation / Fibrosis

Moderate-to-severe conditions, like asthma, atopic dermatitis, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis and food allergies, with limited response to corticosteroid treatment

Retinal

Biobetter multifunctional anti-VEGF antibodies.

MEET OUR TEAM

We are seasoned visionaries committed to advancing treatment for retinal, dermatological, and respiratory diseases.

null

Daniel White

Chief Executive Officer & Director
null

Kirby Alton

Chairman
null

Martin Simonetti

Director
Chris McLeod

Christopher McLeod

Director

Investors

Lanier Biotherapeutics is funded by a group of visionary private investors

If you are interested in further exploring as an investor, please contact us.

Connect with us

Headquarters:

P.O. Box 1071
Jefferson, GA 30549

Lab:
150 Technology Parkway
Room #130
Peachtree Corners, GA 30092

Send message